<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00745446</url>
  </required_header>
  <id_info>
    <org_study_id>VOLVO 3ARM</org_study_id>
    <nct_id>NCT00745446</nct_id>
  </id_info>
  <brief_title>The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation</brief_title>
  <official_title>The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a retrofit particle trap can reduce the
      adverse vascular responses to diesel exhaust inhalation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      18 subjects healthy male volunteers will be recruited at Umeå University. In a randomised,
      double blind 3 way crossover trial, subjects will be exposed to filtered air, diesel exhaust
      (300mcg/m3) or filtered diesel exhaust for 1 hour during intermittent exercise.

      2 hours following the exposure, thrombogenicity will be assessed using the Badimon chamber -
      an ex-vivo model of thrombosis formed under constant flow conditions.

      Forearm blood flow in response to infused intra-brachial vasodilators will be measured using
      venous occlusion plethysmography 6 hours after the exposure.

      Arterial stiffness will be measured using peripheral arterial applanation tonometry in the
      hour post-exposure.

      Blood samples will be collected at timepoints over the 24 hours after exposure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow in response to infused intra-arterial vasodilators</measure>
    <time_frame>6 hours post-exposure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial stiffness measured by applanation tonometry</measure>
    <time_frame>In the 1 hour following exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombogenicity measured using the Badimon chamber - an ex-vivo model of thrombosis under conditions of continuous flow</measure>
    <time_frame>2 hours after the exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exhaled nitric oxide - a marker of pulmonary inflammation</measure>
    <time_frame>1 hour &amp; 6 hours after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endogenous fibrinolytic capacity - measured as net release of t-PA in response to infused bradykinin</measure>
    <time_frame>6 hours after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical markers of systemic inflammation</measure>
    <time_frame>Baseline, 2, 6 &amp; 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Heart Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to filtered air</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to diesel exhaust (300mcg/m3)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to filtered diesel exhaust</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Forearm Venous Occlusion Plethysmography</intervention_name>
    <description>Forearm venous occlusion plethysmography with intra-arterial infusion of Acetylcholine (5-20mcg/min), bradykinin (30-300mcg/min), sodium nitroprusside (2-8mcg/min) and Verapamil (2-10 mcg/min) into non-dominant brachial artery</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers

        Exclusion Criteria:

          -  Intercurrent illness

          -  Smoking

          -  Significant occupational exposure to air pollution

          -  Regular medication usage
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders Blomberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Umeå University</name>
      <address>
        <city>Umeå</city>
        <state>Västerbottens</state>
        <zip>SE-901 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2008</study_first_submitted>
  <study_first_submitted_qc>September 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2008</study_first_posted>
  <last_update_submitted>September 4, 2008</last_update_submitted>
  <last_update_submitted_qc>September 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Anders Blomberg</name_title>
    <organization>Umeå University</organization>
  </responsible_party>
  <keyword>Air pollution</keyword>
  <keyword>Diesel exhaust</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Particle trap</keyword>
  <keyword>Thrombosis</keyword>
  <keyword>effects</keyword>
  <keyword>inhalation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

